ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |

(State or Other Jurisdiction of Incorporation) | (IRS Employer Identification No.) | |||
(Address of Principal Executive Offices) | (Zip Code) |
Title of each class | Trading Symbol | Name of each exchange on which registered | ||
Class A Common Stock, $0.001 par value per share |
☒ | Accelerated filer | ☐ | Non-accelerated filer | ☐ | Smaller reporting company | Emerging growth company |





Year Ended December 31, | ||||||
(in thousands, except percentages and per share data) | 2025 | 2024 | 2023 | |||
Revenue | ||||||
Net commissions and fees | $2,994,582 | $2,455,671 | $2,026,596 | |||
Fiduciary investment income | 56,544 | 60,039 | 50,953 | |||
Total revenue | $3,051,126 | $2,515,710 | $2,077,549 | |||
Expenses | ||||||
Compensation and benefits | 1,803,397 | 1,591,077 | 1,321,029 | |||
General and administrative | 453,452 | 352,050 | 276,181 | |||
Amortization | 274,426 | 157,845 | 106,799 | |||
Depreciation | 13,089 | 9,785 | 9,038 | |||
Change in contingent consideration | 13,122 | (22,859) | 5,421 | |||
Total operating expenses | $2,557,486 | $2,087,898 | $1,718,468 | |||
Operating income | $493,640 | $427,812 | $359,081 | |||
Interest expense, net | 222,384 | 158,448 | 119,507 | |||
Income from equity method investments | (21,236) | (18,231) | (8,731) | |||
Other non-operating loss (income) | (692) | 15,041 | 10,380 | |||
Income before income taxes | $293,184 | $272,554 | $237,925 | |||
Income tax expense | 79,027 | 42,641 | 43,445 | |||
Net income | $214,157 | $229,913 | $194,480 | |||
GAAP financial measures | ||||||
Revenue | $3,051,126 | $2,515,710 | $2,077,549 | |||
Net commissions and fees | 2,994,582 | 2,455,671 | 2,026,596 | |||
Compensation and benefits | 1,803,397 | 1,591,077 | 1,321,029 | |||
General and administrative | 453,452 | 352,050 | 276,181 | |||
Net income | 214,157 | 229,913 | 194,480 | |||
Compensation and benefits expense ratio (1) | 59.1% | 63.2% | 63.6% | |||
General and administrative expense ratio (2) | 14.9% | 14.0% | 13.3% | |||
Net income margin (3) | 7.0% | 9.1% | 9.4% | |||
Earnings per share (4) | $0.50 | $0.78 | $0.53 | |||
Diluted earnings per share (4) | $0.47 | $0.71 | $0.52 | |||
Non-GAAP financial measures* | ||||||
Organic revenue growth rate | 10.1% | 12.8% | 15.4% | |||
Adjusted compensation and benefits expense | $1,692,000 | $1,426,674 | $1,222,342 | |||
Adjusted compensation and benefits expense ratio | 55.5% | 56.7% | 58.8% | |||
Adjusted general and administrative expense | $392,384 | $277,813 | $230,467 | |||
Adjusted general and administrative expense ratio | 12.9% | 11.0% | 11.1% | |||
Adjusted EBITDAC | $966,742 | $811,223 | $624,740 | |||
Adjusted EBITDAC margin | 31.7% | 32.2% | 30.1% | |||
Adjusted net income | $548,219 | $493,521 | $375,582 | |||
Adjusted net income margin | 18.0% | 19.6% | 18.1% | |||
Adjusted diluted earnings per share | $1.96 | $1.79 | $1.38 | |||
Year Ended December 31, | Period over Period | |||||||||||
(in thousands, except percentages) | 2025 | % of total | 2024 | % of total | Change | |||||||
Wholesale Brokerage | $1,600,427 | 53.4% | $1,489,077 | 60.7% | $111,350 | 7.5% | ||||||
Binding Authority | 370,155 | 12.4 | 320,379 | 13.0 | 49,776 | 15.5 | ||||||
Underwriting Management | 1,024,000 | 34.2 | 646,215 | 26.3 | 377,785 | 58.5 | ||||||
Total Net commissions and fees | $2,994,582 | $2,455,671 | $538,911 | 21.9% | ||||||||
Year Ended December 31, | Period over Period | |||||||||||
(in thousands, except percentages) | 2025 | % of total | 2024 | % of total | Change | |||||||
Net commissions and policy fees | $2,759,597 | 92.1% | $2,310,384 | 94.1% | $449,213 | 19.4% | ||||||
Supplemental and contingent commissions | 149,237 | 5.0 | 88,842 | 3.6 | 60,395 | 68.0 | ||||||
Loss mitigation and other fees | 85,748 | 2.9 | 56,445 | 2.3 | 29,303 | 51.9 | ||||||
Total Net commissions and fees | $2,994,582 | $2,455,671 | $538,911 | 21.9% | ||||||||
Year Ended December 31, | Period over Period | |||||||||||
(in thousands, except percentages) | 2024 | % of total | 2023 | % of total | Change | |||||||
Wholesale Brokerage | $1,489,077 | 60.7% | $1,319,056 | 65.1% | $170,021 | 12.9% | ||||||
Binding Authority | 320,379 | 13.0 | 275,961 | 13.6 | 44,418 | 16.1 | ||||||
Underwriting Management | 646,215 | 26.3 | 431,579 | 21.3 | 214,636 | 49.7 | ||||||
Total Net commissions and fees | $2,455,671 | $2,026,596 | $429,075 | 21.2% | ||||||||
Year Ended December 31, | Period over Period | |||||||||||
(in thousands, except percentages) | 2024 | % of total | 2023 | % of total | Change | |||||||
Net commissions and policy fees | $2,310,384 | 94.1% | $1,935,851 | 95.5% | $374,533 | 19.3% | ||||||
Supplemental and contingent commissions | 88,842 | 3.6 | 56,375 | 2.8 | 32,467 | 57.6 | ||||||
Loss mitigation and other fees | 56,445 | 2.3 | 34,370 | 1.7 | 22,075 | 64.2 | ||||||
Total Net commissions and fees | $2,455,671 | $2,026,596 | $429,075 | 21.2% | ||||||||
Year Ended December 31, | ||||||
(in thousands, except percentages) | 2025 | 2024 | 2023 | |||
Current period Net commissions and fees revenue | $2,994,582 | $2,455,671 | $2,026,596 | |||
Less: Current period contingent commissions | (121,549) | (73,175) | (39,028) | |||
Less: Revenue attributable to sold businesses | (361) | — | — | |||
Net commissions and fees revenue excluding contingent commissions | $2,872,672 | $2,382,496 | $1,987,568 | |||
Prior period Net commissions and fees revenue | $2,455,671 | $2,026,596 | $1,711,861 | |||
Less: Prior period contingent commissions | (73,175) | (39,028) | (30,788) | |||
Less: Revenue attributable to sold businesses | (1,941) | — | — | |||
Prior period Net commissions and fees revenue excluding contingent commissions | $2,380,555 | $1,987,568 | $1,681,073 | |||
Change in Net commissions and fees revenue excluding contingent commissions | $492,117 | $394,928 | $306,494 | |||
Less: Mergers and acquisitions Net commissions and fees revenue excluding contingent commissions | (246,914) | (141,972) | (46,496) | |||
Impact of change in foreign exchange rates | (4,863) | (791) | (479) | |||
Organic revenue growth (Non-GAAP) | $240,340 | $252,165 | $259,519 | |||
Net commissions and fees revenue growth rate (GAAP) | 21.9 % | 21.2 % | 18.4 % | |||
Less: Impact of contingent commissions (1) | (1.2) | (1.3) | (0.2) | |||
Net commissions and fees revenue excluding contingent commissions growth rate (2) | 20.7 % | 19.9 % | 18.2 % | |||
Less: Mergers and acquisitions Net commissions and fees revenue excluding contingent commissions (3) | (10.4) | (7.1) | (2.8) | |||
Impact of change in foreign exchange rates (4) | (0.2) | 0.0 | 0.0 | |||
Organic Revenue Growth Rate (Non-GAAP) | 10.1 % | 12.8 % | 15.4 % | |||
Year Ended December 31, | ||||||
(in thousands, except percentages) | 2025 | 2024 | 2023 | |||
Total Revenue | $3,051,126 | $2,515,710 | $2,077,549 | |||
Compensation and Benefits Expense | $1,803,397 | $1,591,077 | $1,321,029 | |||
Acquisition-related expense | (11,033) | (15,373) | (4,186) | |||
Acquisition related long-term incentive compensation (1) | (26,581) | (24,946) | 4,334 | |||
Restructuring and related expense | — | (39,929) | (22,651) | |||
Amortization and expense related to discontinued prepaid incentives | (4,332) | (5,160) | (6,441) | |||
Equity-based compensation (2) | (49,664) | (52,038) | (31,047) | |||
IPO related expenses | (19,787) | (26,957) | (38,696) | |||
Adjusted Compensation and Benefits Expense (3) | $1,692,000 | $1,426,674 | $1,222,342 | |||
Compensation and Benefits Expense Ratio | 59.1% | 63.2% | 63.6% | |||
Adjusted Compensation and Benefits Expense Ratio | 55.5% | 56.7% | 58.8% | |||
Year Ended December 31, | ||||||
(in thousands, except percentages) | 2025 | 2024 | 2023 | |||
Total Revenue | $3,051,126 | $2,515,710 | $2,077,549 | |||
General and Administrative Expense | $453,452 | $352,050 | $276,181 | |||
Acquisition-related expense | (61,068) | (54,469) | (19,088) | |||
Restructuring and related expense | — | (19,768) | (26,626) | |||
Adjusted General and Administrative Expense (1) | $392,384 | $277,813 | $230,467 | |||
General and Administrative Expense Ratio | 14.9% | 14.0% | 13.3% | |||
Adjusted General and Administrative Expense Ratio | 12.9% | 11.0% | 11.1% | |||
Year Ended December 31, | ||||||
(in thousands, except percentages) | 2025 | 2024 | 2023 | |||
Total Revenue | $3,051,126 | $2,515,710 | $2,077,549 | |||
Net Income | $214,157 | $229,913 | $194,480 | |||
Interest expense, net | 222,384 | 158,448 | 119,507 | |||
Income tax expense | 79,027 | 42,641 | 43,445 | |||
Depreciation | 13,089 | 9,785 | 9,038 | |||
Amortization | 274,426 | 157,845 | 106,799 | |||
Change in contingent consideration (1) | 13,122 | (22,859) | 5,421 | |||
EBITDAC | $816,205 | $575,773 | $478,690 | |||
Acquisition-related expense | 72,101 | 69,842 | 23,274 | |||
Acquisition related long-term incentive compensation (2) | 26,581 | 24,946 | (4,334) | |||
Restructuring and related expense | — | 59,697 | 49,277 | |||
Amortization and expense related to discontinued prepaid incentives | 4,332 | 5,160 | 6,441 | |||
Other non-operating loss (income) | (692) | 15,041 | 10,380 | |||
Equity-based compensation | 49,664 | 52,038 | 31,047 | |||
IPO related expenses | 19,787 | 26,957 | 38,696 | |||
Income from equity method investments | (21,236) | (18,231) | (8,731) | |||
Adjusted EBITDAC | $966,742 | $811,223 | $624,740 | |||
Net Income Margin | 7.0% | 9.1% | 9.4% | |||
Adjusted EBITDAC Margin | 31.7% | 32.2% | 30.1% | |||
Year Ended December 31, | ||||||
(in thousands, except percentages) | 2025 | 2024 | 2023 | |||
Total Revenue | $3,051,126 | $2,515,710 | $2,077,549 | |||
Net Income | $214,157 | $229,913 | $194,480 | |||
Income tax expense | 79,027 | 42,641 | 43,445 | |||
Amortization | 274,426 | 157,845 | 106,799 | |||
Amortization of deferred debt issuance costs (1) | 9,567 | 23,930 | 12,172 | |||
Change in contingent consideration | 13,122 | (22,859) | 5,421 | |||
Acquisition-related expense | 72,101 | 69,842 | 23,274 | |||
Acquisition related long-term incentive compensation | 26,581 | 24,946 | (4,334) | |||
Restructuring and related expense | — | 59,697 | 49,277 | |||
Amortization and expense related to discontinued prepaid incentives | 4,332 | 5,160 | 6,441 | |||
Other non-operating loss (income) | (692) | 15,041 | 10,380 | |||
Equity-based compensation | 49,664 | 52,038 | 31,047 | |||
IPO related expenses | 19,787 | 26,957 | 38,696 | |||
Income from equity method investments | (21,236) | (18,231) | (8,731) | |||
Adjusted Income before Income Taxes (2) | $740,836 | $666,920 | $508,367 | |||
Adjusted tax expense (3) | (192,617) | (173,399) | (132,785) | |||
Adjusted Net Income | $548,219 | $493,521 | $375,582 | |||
Net Income Margin | 7.0% | 9.1% | 9.4% | |||
Adjusted Net Income Margin | 18.0% | 19.6% | 18.1% | |||
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Earnings per share of Class A common stock – diluted | $0.47 | $0.71 | $0.52 | |||
Less: Net income attributed to dilutive shares and substantively vested RSUs (1) | (0.01) | — | (0.03) | |||
Plus: Impact of all LLC Common Units exchanged for Class A shares (2) | 0.32 | 0.14 | 0.24 | |||
Plus: Adjustments to Adjusted net income (3) | 1.22 | 0.97 | 0.67 | |||
Plus: Dilutive impact of unvested equity awards (4) | (0.04) | (0.03) | (0.02) | |||
Adjusted diluted earnings per share | $1.96 | $1.79 | $1.38 | |||
(Share count in ’000s) | ||||||
Weighted-average shares of Class A common stock outstanding – diluted | 138,246 | 132,891 | 125,745 | |||
Plus: Impact of all LLC Common Units exchanged for Class A shares (2) | 135,429 | 138,980 | 142,384 | |||
Plus: Dilutive impact of unvested equity awards (4) | 5,354 | 4,417 | 4,137 | |||
Adjusted diluted earnings per share diluted share count | 279,029 | 276,288 | 272,266 | |||
(in thousands) | Exchange Tax Attributes | Pre-IPO M&A Tax Attributes | TRA Payment Tax Attributes | TRA Liabilities | ||||
Balance at December 31, 2024 | $253,233 | $83,415 | $99,648 | $436,296 | ||||
Exchange of LLC Common Units | 34,813 | 2,466 | 9,479 | 46,758 | ||||
Interest expense | — | — | 1,112 | 1,112 | ||||
Payments | (16,067) | (8,532) | (570) | (25,169) | ||||
Balance at December 31, 2025 | $271,979 | $77,349 | $109,669 | $458,997 |
Long-term Incentive Compensation Agreements | ||
(in thousands) | December 31, 2025 | |
Current accrued compensation | $10,752 | |
Non-current accrued compensation | 19,212 | |
Total liability | $29,963 | |
Projected future expense | 44,880 | |
Total projected future cash outflows | $74,843 | |
Projected Future Cash Outflows | ||
(in thousands) | ||
2026 | $14,632 | |
2027 | 9,274 | |
2028 | 32,257 | |
2029 | 11,048 | |
Thereafter | $7,632 | |
Contingent Consideration | ||
(in thousands) | December 31, 2025 | |
Current accounts payable and accrued liabilities | $55,880 | |
Other non-current liabilities | 92,508 | |
Total liability | $148,388 | |
Projected future expense | 10,429 | |
Total projected future cash outflows | $158,817 | |
Projected Future Cash Outflows | ||
(in thousands) | ||
2026 | $57,255 | |
2027 | 89,016 | |
2028 | 6,262 | |
2029 | 4,662 | |
Thereafter | $1,622 | |
(in thousands) | Balance at December 31, 2025 | 100 BPS Increase | 100 BPS Decrease | |||
Cash and cash equivalents | $158,322 | $(1,583) | $1,583 | |||
Term Loan principal outstanding (1) | 1,683,000 | 16,830 | $(16,830) | |||
Net exposure to Interest expense, net | 15,247 | (15,247) | ||||
Cash and cash equivalents held in a fiduciary capacity | 1,426,148 | 14,261 | $(14,261) | |||
Net exposure to Fiduciary investment income | $14,261 | $(14,261) | ||||
Impact to Net income | $(985) | $985 |
Consolidated Statements of Comprehensive Income for the years ended December 31, 2025, 2024, and 2023 | |
Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2025, 2024, and 2023 | |
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
REVENUE | ||||||
Net commissions and fees | $ | $ | $ | |||
Fiduciary investment income | ||||||
Total revenue | $ | $ | $ | |||
EXPENSES | ||||||
Compensation and benefits | ||||||
General and administrative | ||||||
Amortization | ||||||
Depreciation | ||||||
Change in contingent consideration | ( | |||||
Total operating expenses | $ | $ | $ | |||
OPERATING INCOME | $ | $ | $ | |||
Interest expense, net | ||||||
Income from equity method investments | ( | ( | ( | |||
Other non-operating loss (income) | ( | |||||
INCOME BEFORE INCOME TAXES | $ | $ | $ | |||
Income tax expense | ||||||
NET INCOME | $ | $ | $ | |||
Net income attributable to non-controlling interests, net of tax | ||||||
NET INCOME ATTRIBUTABLE TO RYAN SPECIALTY HOLDINGS, INC. | $ | $ | $ | |||
NET INCOME PER SHARE OF CLASS A COMMON STOCK: | ||||||
Basic | $ | $ | $ | |||
Diluted | $ | $ | $ | |||
WEIGHTED-AVERAGE SHARES OF CLASS A COMMON STOCK OUTSTANDING: | ||||||
Basic | ||||||
Diluted | ||||||
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
NET INCOME | $ | $ | $ | |||
Net income attributable to non-controlling interests, net of tax | ||||||
NET INCOME ATTRIBUTABLE TO RYAN SPECIALTY HOLDINGS, INC. | $ | $ | $ | |||
Other comprehensive income (loss), net of tax: | ||||||
Gain on interest rate cap | ||||||
Gain on interest rate cap reclassified to earnings | ( | ( | ( | |||
Foreign currency translation adjustments | ( | |||||
Change in share of equity method investments’ other comprehensive income (loss) | ( | |||||
Total other comprehensive income (loss), net of tax | $ | $( | $( | |||
COMPREHENSIVE INCOME ATTRIBUTABLE TO RYAN SPECIALTY HOLDINGS, INC. | $ | $ | $ | |||
December 31, 2025 | December 31, 2024 | |||
ASSETS | ||||
CURRENT ASSETS | ||||
Cash and cash equivalents | $ | $ | ||
Commissions and fees receivable – net | ||||
Fiduciary cash and receivables | ||||
Prepaid incentives – net | ||||
Other current assets | ||||
Total current assets | $ | $ | ||
NON-CURRENT ASSETS | ||||
Goodwill | ||||
Customer relationships | ||||
Other intangible assets | ||||
Prepaid incentives – net | ||||
Equity method investments | ||||
Property and equipment – net | ||||
Lease right-of-use assets | ||||
Deferred tax assets | ||||
Other non-current assets | ||||
Total non-current assets | $ | $ | ||
TOTAL ASSETS | $ | $ | ||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||
CURRENT LIABILITIES | ||||
Accounts payable and accrued liabilities | $ | $ | ||
Accrued compensation | ||||
Operating lease liabilities | ||||
Short-term debt and current portion of long-term debt | ||||
Fiduciary liabilities | ||||
Total current liabilities | $ | $ | ||
NON-CURRENT LIABILITIES | ||||
Accrued compensation | ||||
Operating lease liabilities | ||||
Long-term debt | ||||
Tax Receivable Agreement liabilities | ||||
Deferred tax liabilities | ||||
Other non-current liabilities | ||||
Total non-current liabilities | $ | $ | ||
TOTAL LIABILITIES | $ | $ | ||
STOCKHOLDERS’ EQUITY | ||||
Class A common stock ($ shares issued and outstanding at December 31, 2025 and 2024, respectively) | ||||
Class B common stock ($ shares issued and outstanding at December 31, 2025 and 2024, respectively) | ||||
Class X common stock ($ | ||||
Preferred stock ($ December 31, 2025 and 2024) | ||||
Additional paid-in capital | ||||
Retained earnings | ||||
Accumulated other comprehensive income (loss) | ( | |||
Total stockholders’ equity attributable to Ryan Specialty Holdings, Inc. | $ | $ | ||
Non-controlling interests | ||||
Total stockholders’ equity | $ | $ | ||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | $ |
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||
Net income | $ | $ | $ | |||
Adjustments to reconcile net income to cash flows provided by operating activities: | ||||||
Income from equity method investments | ( | ( | ( | |||
Amortization | ||||||
Depreciation | ||||||
Prepaid and deferred compensation expense | ||||||
Non-cash equity-based compensation | ||||||
Amortization of deferred debt issuance costs | ||||||
Amortization of interest rate cap premium | ||||||
Deferred income tax expense | ||||||
Deferred income tax expense from common control reorganizations | ||||||
Loss (gain) on Tax Receivable Agreement | ( | |||||
Changes in operating assets and liabilities, net of acquisitions: | ||||||
Commissions and fees receivable – net | ( | ( | ( | |||
Accrued interest liability | ||||||
Other current and non-current assets | ( | |||||
Other current and non-current liabilities | ( | |||||
Total cash flows provided by operating activities | $ | $ | $ | |||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||
Business combinations – net of cash acquired and cash held in a fiduciary capacity | ( | ( | ( | |||
Capital expenditures | ( | ( | ( | |||
Equity method investment in VSIC | ( | |||||
Asset acquisitions | ( | |||||
Repayments of prepaid incentives | ||||||
Total cash flows used in investing activities | $( | $( | $( | |||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||
Proceeds from Senior Secured Notes | ||||||
Borrowings on Revolving Credit Facility | ||||||
Repayments on Revolving Credit Facility | ( | ( | ||||
Debt issuance costs paid | ( | ( | ||||
Proceeds from term debt | ||||||
Repayment of term debt | ( | ( | ( | |||
Receipt of contingently returnable consideration | ||||||
Payment of contingent consideration | ( | ( | ||||
Tax distributions to non-controlling LLC Unitholders | ( | ( | ( | |||
Receipt of taxes related to net share settlement of equity awards | ||||||
Taxes paid related to net share settlement of equity awards | ( | ( | ( | |||
Payment of Tax Receivable Agreement liabilities | ( | ( | ( | |||
Class A common stock dividends and Dividend Equivalents paid | ( | ( | ||||
Distributions and Declared Distributions paid to non-controlling LLC Unitholders | ( | ( | ||||
Payments related to Ryan Re preferred units | ( | ( | ||||
Net change in fiduciary liabilities | ||||||
Total cash flows provided by (used in) financing activities | $ | $ | $( | |||
Effect of changes in foreign exchange rates on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | ( | |||||
NET CHANGE IN CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY | $( | $( | $( | |||
CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY—Beginning balance | ||||||
CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY—Ending balance | $ | $ | $ | |||
Reconciliation of cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | ||||||
Cash and cash equivalents | $ | $ | $ | |||
Cash and cash equivalents held in a fiduciary capacity | ||||||
Total cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity | $ | $ | $ | |||
Class A Common Stock | Class B Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Non- controlling Interests | Total Stockholders’ Equity | ||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||
Balance at December 31, 2022 | $ | $ | $ | $ | $ | $ | $ | |||||||||||
Net income | — | — | — | — | — | — | ||||||||||||
Issuance of common stock | — | — | ||||||||||||||||
Forfeiture and retirement of common stock and clawback of vested equity awards | ( | — | — | — | ( | — | — | ( | ||||||||||
Exchange of LLC equity for common stock | ( | ( | — | — | ( | |||||||||||||
Equity awards withheld for settlement of employee tax obligations | — | — | — | — | — | — | — | ( | ( | |||||||||
Tax Receivable Agreement liability and deferred taxes arising from LLC interest ownership changes | — | — | — | — | ( | — | — | ( | ||||||||||
Distributions declared for non-controlling interest holders’ tax | — | — | — | — | — | — | — | ( | ( | |||||||||
Change in share of equity method investment’s other comprehensive loss | — | — | — | — | — | — | ( | ( | ( | |||||||||
Loss on interest rate cap, net | — | — | — | — | — | — | ( | ( | ( | |||||||||
Foreign currency translation adjustments | — | — | — | — | — | — | ||||||||||||
Equity-based compensation | — | — | — | — | — | — | ||||||||||||
Balance at December 31, 2023 | $ | $ | $ | $ | $ | $ | $ | |||||||||||
Net income | — | — | — | — | — | — | ||||||||||||
Issuance of common stock | — | — | — | |||||||||||||||
Forfeiture and retirement of common stock and clawback of vested equity awards | ( | — | — | — | ( | — | — | ( | ||||||||||
Exchange of LLC equity for common stock | ( | ( | — | — | ( | |||||||||||||
Equity awards withheld for settlement of employee tax obligations | — | — | — | — | — | — | — | ( | ( | |||||||||
Class A common stock dividends and Dividend Equivalents | — | — | — | — | — | ( | — | — | ( | |||||||||
Distributions and Declared Distributions to non- controlling LLC Unitholders | — | — | — | — | — | — | — | ( | ( | |||||||||
Tax Receivable Agreement liability and deferred taxes arising from LLC interest ownership changes | — | — | — | — | ( | — | — | |||||||||||
Distributions declared for non-controlling interest holders’ tax | — | — | — | — | — | — | — | ( | ( | |||||||||
Change in share of equity method investment’s other comprehensive income | — | — | — | — | — | — | ||||||||||||
Loss on interest rate cap, net | — | — | — | — | — | — | ( | ( | ( | |||||||||
Foreign currency translation adjustments | — | — | — | — | — | — | ( | ( | ( | |||||||||
Equity-based compensation | — | — | — | — | — | — | ||||||||||||
Balance at December 31, 2024 | $ | $ | $ | $ | $( | $ | $ | |||||||||||
Class A Common Stock | Class B Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Non- controlling Interests | Total Stockholders’ Equity | ||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||
Balance at December 31, 2024 | $ | $ | $ | $ | $( | $ | $ | |||||||||||
Net income | — | — | — | — | — | — | ||||||||||||
Issuance of common stock | — | — | ||||||||||||||||
Cash and common stock clawbacks related to vested equity awards | ( | — | — | — | ( | — | ||||||||||||
Exchange of LLC equity for common stock | ( | ( | — | — | ( | |||||||||||||
Equity awards withheld for settlement of employee tax obligations | — | — | — | — | ( | — | — | ( | ( | |||||||||
Class A common stock dividends and Dividend Equivalents | — | — | — | — | — | ( | — | — | ( | |||||||||
Distributions and Declared Distributions to non- controlling LLC Unitholders | — | — | — | — | — | — | — | ( | ( | |||||||||
Tax Receivable Agreement liability and deferred taxes arising from LLC interest ownership changes | — | — | — | — | ( | — | — | ( | ||||||||||
Distributions declared for non-controlling interest holders’ tax | — | — | — | — | — | — | — | ( | ( | |||||||||
Change in share of equity method investments’ other comprehensive income | — | — | — | — | — | — | ||||||||||||
Loss on interest rate cap, net | — | — | — | — | — | — | ( | ( | ( | |||||||||
Foreign currency translation adjustments | — | — | — | — | — | — | ||||||||||||
Equity-based compensation | — | — | — | — | — | — | ||||||||||||
Balance at December 31, 2025 | $ | $ | $ | $ | $ | $ | $ | |||||||||||
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Wholesale Brokerage | $ | $ | $ | |||
Binding Authority | ||||||
Underwriting Management | ||||||
Total Net commissions and fees | $ | $ | $ | |||
Velocity | USQ | 360 | JM Wilson | SSRU | Total | |||||||
Cash and cash equivalents | $ | $ | $ | $ | $ | $ | ||||||
Commissions and fees receivable – net | ||||||||||||
Fiduciary cash and receivables | ||||||||||||
Goodwill | ||||||||||||
Customer relationships1 | ||||||||||||
Other intangible assets | ||||||||||||
Property and equipment – net | ||||||||||||
Lease right-of-use assets | ||||||||||||
Other current and non-current assets | ||||||||||||
Total assets acquired | $ | $ | $ | $ | $ | $ | ||||||
Accounts payable and accrued liabilities | ||||||||||||
Accrued compensation | ||||||||||||
Fiduciary liabilities | ||||||||||||
Operating lease liabilities | ||||||||||||
Deferred tax liabilities | ||||||||||||
Total liabilities assumed | $ | $ | $ | $ | $ | $ | ||||||
Net assets acquired | $ | $ | $ | $ | $ | $ |
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Total revenue | $ | $ | $ | |||
Net income | ||||||
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Change in contingent consideration | $ | $( | $ | |||
Interest expense, net | ||||||
Total | $ | $( | $ | |||
Year Ended December 31, | ||||
2025 | 2024 | |||
Balance at beginning of period | $ | $ | ||
Write-offs | ( | ( | ||
Increase in provision | ||||
Balance at end of period | $ | $ | ||
As of December 31, | ||||
2025 | 2024 | |||
Prepaid expenses | $ | $ | ||
Insurance recoverable | ||||
Interest rate cap | ||||
Other current receivables | ||||
Total Other current assets | $ | $ | ||
Year Ended December 31, | ||||
2025 | 2024 | |||
Balance at beginning of period | $ | $ | ||
Acquisitions1 | ||||
Measurement period adjustments | ||||
Impact of exchange rate changes | ( | |||
Balance at end of period | $ | $ | ||
As of December 31, 2025 | As of December 31, 2024 | |||||||||||
Cost | Accumulated Amortization | Net Carrying Amount | Cost | Accumulated Amortization | Net Carrying Amount | |||||||
Customer relationships | $ | $( | $ | $ | $( | $ | ||||||
Internally developed software | ( | ( | ||||||||||
Other1 | ( | ( | ||||||||||
Total | $ | $( | $ | $ | $( | $ | ||||||
Customer Relationships | Internally Developed Software | Other | ||||
2026 | $ | $ | $ | |||
2027 | ||||||
2028 | ||||||
2029 | ||||||
2030 | ||||||
Thereafter | ||||||
Total | $ | $ | $ |
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Lease costs | ||||||
Operating lease costs | $ | $ | $ | |||
Short-term lease costs | ||||||
Operating lease costs | ||||||
Sublease income | ( | ( | ( | |||
Lease costs – net | $ | $ | $ | |||
Cash paid for amounts included in the measurement of lease liabilities | ||||||
Operating cash flows used for operating leases | $ | $ | $ | |||
Non-cash related activities | ||||||
Right-of-use assets obtained in exchange for new operating lease liabilities | ||||||
Amortization of right-of-use assets for operating leases | ||||||
Weighted-average discount rate (percent) | ||||||
Operating leases | ||||||
Weighted-average remaining lease term (years) | ||||||
Operating leases | ||||||
2026 | $ | |
2027 | ||
2028 | ||
2029 | ||
2030 | ||
Thereafter | ||
Total undiscounted future lease payments | $ | |
Less: Imputed interest | ( | |
Present value lease liabilities | $ |
As of December 31, | ||||
2025 | 2024 | |||
Term debt | ||||
Adjusted Term SOFR + SOFR + | $ | $ | ||
Senior secured notes | ||||
February 1, 2030 | ||||
August 1, 2032 | ||||
Revolving debt | ||||
SOFR + up to July 30, 2029 | ||||
Premium financing notes | ||||
Commercial notes, periodic interest and principal payments, expire May 1, 2026 | ||||
Commercial notes, periodic interest and principal payments, expire June 1, 2026 | ||||
Commercial notes, periodic interest and principal payments, expire June 21, 2026 | ||||
Commercial notes, periodic interest and principal payments, expired May 1, 2025 | ||||
Commercial notes, periodic interest and principal payments, expired June 1, 2025 | ||||
Commercial notes, periodic interest and principal payments, expired June 21, 2025 | ||||
Units subject to mandatory redemption | ||||
Total debt | $ | $ | ||
Less: Short-term debt and current portion of long-term debt | ( | ( | ||
Long-term debt | $ | $ | ||
2026 | $ | |
2027 | ||
2028 | ||
2029 | ||
2030 | ||
Thereafter | ||
Total repayments | $ | |
Less: Unamortized discounts and debt issuance costs | ( | |
Total | $ |
Year Ended December 31, 2025 | ||||||||
Restricted Stock | Weighted Average Grant Date Fair Value | Restricted Common Units | Weighted Average Grant Date Fair Value | |||||
Unvested at beginning of period | $ | $ | ||||||
Granted | ||||||||
Vested | ( | ( | ||||||
Forfeited | ( | |||||||
Unvested at end of period | $ | $ | ||||||
Year Ended December 31, 2025 | ||||||||
IPO RSUs | Incentive RSUs | |||||||
Restricted Stock Units | Weighted Average Grant Date Fair Value | Restricted Stock Units | Weighted Average Grant Date Fair Value | |||||
Unvested at beginning of period | $ | $ | ||||||
Granted | ||||||||
Vested | ( | ( | ||||||
Forfeited | ( | ( | ||||||
Unvested at end of period | $ | $ | ||||||
Year Ended December 31, 2025 | ||||||||
Reload Options1 | Staking Options1 | Incentive Options | Incentive Options Weighted Average Exercise Price | |||||
Outstanding at beginning of period | $ | |||||||
Granted | ||||||||
Exercised | ( | ( | ||||||
Forfeited or expired | ( | ( | ||||||
Outstanding at end of period | $ | |||||||
Volatility | ||
Time to maturity (years) | ||
Risk-free rate | ||
Dividend yield | ||
Fair value per option | $ |
Aggregate intrinsic value ($ in thousands): | ||
Reload Options outstanding | $ | |
Reload Options exercisable | ||
Staking Options outstanding | ||
Staking Options exercisable | ||
Incentive Options outstanding | ||
Incentive Options exercisable | ||
Weighted-average remaining contractual term (in years): | ||
Reload Options outstanding | ||
Reload Options exercisable | ||
Staking Options outstanding | ||
Staking Options exercisable | ||
Incentive Options outstanding | ||
Incentive Options exercisable |
Year Ended December 31, 2025 | ||||||||
IPO RLUs | Incentive RLUs | |||||||
Restricted LLC Units | Weighted Average Grant Date Fair Value | Restricted LLC Units | Weighted Average Grant Date Fair Value | |||||
Unvested at beginning of period | $ | $ | ||||||
Granted | ||||||||
Vested | ( | ( | ||||||
Forfeited | ||||||||
Unvested at end of period | $ | $ | ||||||
Year Ended December 31, 2025 | ||||||||
Reload Class C Incentive Units | Staking Class C Incentive Units | Class C Incentive Units | Class C Incentive Units Weighted Average Participation Threshold | |||||
Unvested at beginning of period | $ | |||||||
Granted | ||||||||
Vested | ( | ( | ( | |||||
Forfeited | ||||||||
Unvested at end of period | $ | |||||||
Year Ended December 31, 2025 | ||||||||
PSUs | PLUs | |||||||
Performance Stock Units | Weighted Average Grant Date Fair Value | Performance LLC Units | Weighted Average Grant Date Fair Value | |||||
Unvested at beginning of period | $ | $ | ||||||
Granted | ||||||||
Vested | ||||||||
Forfeited | ( | |||||||
Unvested at end of period | $ | $ | ||||||
Year Ended December 31, | ||||
2025 | 2024 | |||
Volatility | ||||
Time to maturity (years) | ||||
Risk-free rate | ||||
RYAN stock price at valuation date | $ | $ | ||
Amount | Weighted Average Remaining Expense Period (Years) | |||
IPO RSUs | $ | |||
Incentive RSUs | ||||
Reload Options | ||||
Incentive Options | ||||
PSUs | ||||
IPO RLUs | ||||
Incentive RLUs | ||||
Reload Class C Incentive Units | ||||
Staking Class C Incentive Units | ||||
Class C Incentive Units | ||||
Total unrecognized equity-based compensation expense | $ |
Recognized | |||||
Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
IPO awards | |||||
IPO RSUs and Staking Options | $ | $ | $ | ||
IPO RLUs and Staking Class C Incentive Units | |||||
Incremental Restricted Stock and Reload Options | |||||
Incremental Restricted Common Units and Reload Class C Incentive Units | |||||
Pre-IPO incentive awards | |||||
Restricted Stock | |||||
Restricted Common Units | |||||
Post-IPO incentive awards | |||||
Incentive RSUs | |||||
Incentive RLUs | |||||
Incentive Options | |||||
Class C Incentive Units | |||||
PSUs | |||||
PLUs | ( | ||||
Other expense | |||||
Director Stock Grants | |||||
Total equity-based compensation expense | $ | $ | $ | ||
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Net income | $ | $ | $ | |||
Less: Net income attributable to non-controlling interests | ||||||
Net income attributable to Ryan Specialty Holdings, Inc. | $ | $ | $ | |||
Numerator: | ||||||
Net income attributable to Class A common shareholders | $ | $ | $ | |||
Add (less): Income attributed to substantively vested RSUs | ( | |||||
Net income attributable to Class A common shareholders – basic | $ | $ | $ | |||
Add: Income attributed to dilutive shares | ||||||
Net income attributable to Class A common shareholders – diluted | $ | $ | $ | |||
Denominator: | ||||||
Weighted-average shares of Class A common stock outstanding – basic | ||||||
Add: Dilutive shares | ||||||
Weighted-average shares of Class A common stock outstanding – diluted | ||||||
Earnings per share | ||||||
Earnings per share of Class A common stock – basic | $ | $ | $ | |||
Earnings per share of Class A common stock – diluted | $ | $ | $ | |||
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Conversion of non-controlling interest LLC Common Units1 | ||||||
Conversion of vested Class C Incentive Units1 | ||||||
Class C Incentive Units | ||||||
Year Ended December 31, | |||||||
Income Statement Caption | 2025 | 2024 | 2023 | ||||
Change in the fair value of the Deal- Contingent Forward | General and administrative | $ | $( | $( | |||
Total impact of derivatives not designated as hedging instruments | $ | $( | $( | ||||
Interest rate cap premium amortization | Interest expense, net | $( | $( | $( | |||
Amounts reclassified out of other comprehensive income related to the interest rate cap | Interest expense, net | ||||||
Total impact of derivatives designated as hedging instruments | $ | $ | $ | ||||
As of December 31, | |||||
Balance Sheet Caption | 2025 | 2024 | |||
Interest rate cap | Other current assets | $ | $ | ||
As of December 31, 2025 | As of December 31, 2024 | |||||||||||
Level 1 | Level 2 | Level 3 | Level 1 | Level 2 | Level 3 | |||||||
Assets | ||||||||||||
Interest rate cap | $ | $ | $ | $ | $ | $ | ||||||
Contingently returnable consideration | ||||||||||||
Liabilities | ||||||||||||
Contingent consideration | ||||||||||||
Total assets and liabilities measured at fair value | $ | $ | $ | $ | $ | $ | ||||||
Year Ended December 31, | ||||
2025 | 2024 | |||
Assets | ||||
Balance at beginning of period | $ | $ | ||
Newly established assets due to acquisitions | ||||
Total gains included in earnings | ||||
Foreign currency translation adjustments included in OCI | ( | |||
Settlements | ( | |||
Balance at end of period | $ | $ | ||
Liabilities | ||||
Balance at beginning of period | $ | $ | ||
Newly established liabilities due to acquisitions1 | ||||
Total (gains) losses included in earnings | ( | |||
Foreign currency translation adjustments included in OCI | ||||
Settlements | ( | ( | ||
Acquisition measurement period adjustments | ( | |||
Balance at end of period | $ | $ | ||
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
United States | $ | $ | $ | |||
Foreign | ( | |||||
Income before income taxes | $ | $ | $ | |||
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Current income tax expense (benefit) | ||||||
Federal | $( | $ | $ | |||
State | ||||||
Foreign | ||||||
Current income tax expense | $ | $ | $ | |||
Deferred income tax expense (benefit) | ||||||
Federal | ||||||
State | ( | |||||
Foreign | ( | ( | ( | |||
Deferred income tax expense | $ | $ | $ | |||
Total income tax expense (benefit) | ||||||
Federal | ||||||
State | ( | |||||
Foreign | ( | |||||
Total income tax expense | $ | $ | $ | |||
Year Ended December 31, | ||||||||||||
2025 | 2024 | 2023 | ||||||||||
Income taxes at U.S. federal statutory rate | $ | $ | $ | |||||||||
Nontaxable and nondeductible items | ||||||||||||
Income attributable to non-controlling interests and nontaxable income | ( | ( | ( | ( | ( | ( | ||||||
Nondeductible expenses | ||||||||||||
Effect of cross-border tax laws | ( | ( | ( | ( | ||||||||
Changes in valuation allowances | ||||||||||||
Equity-based compensation | ( | ( | ( | ( | ( | ( | ||||||
Common Control Reorganizations1 | ||||||||||||
Change in fair value of contingent consideration2 | ||||||||||||
Other federal | ( | ( | ( | ( | ||||||||
State and local income tax expense (benefit), net of federal benefit3 | ( | ( | ||||||||||
Foreign tax effects | ||||||||||||
United Kingdom | ||||||||||||
Nondeductible acquisition expenses | ||||||||||||
Nontaxable dividends and profit distributions | ( | ( | ||||||||||
Other | ( | ( | ||||||||||
Spain | ||||||||||||
Nondeductible profit distributions | ||||||||||||
Other | ( | ( | ||||||||||
Other foreign jurisdictions | ( | ( | ||||||||||
Income tax expense | $ | $ | $ | |||||||||
As of December 31, | ||||
2025 | 2024 | |||
Deferred tax assets | ||||
Net operating losses | $ | $ | ||
Investment in the LLC | ||||
Start-up costs | ||||
Equity-based compensation | ||||
Tax credits | ||||
Capitalized research and development | ||||
Other accrued items | ||||
Total deferred tax assets | $ | $ | ||
Valuation allowances | ( | ( | ||
Deferred tax assets, net of valuation allowances | $ | $ | ||
Deferred tax liabilities | ||||
Intangibles | ( | ( | ||
Fixed assets | ( | |||
Other accrued items | ||||
Deferred tax liabilities | $( | $( | ||
Net Deferred tax assets | $ | $ | ||
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Federal | $ | $ | $ | |||
State and local | ||||||
Texas | ||||||
New York City | ||||||
Other state and local | ||||||
Foreign | ||||||
United Kingdom | ||||||
Netherlands | ||||||
Spain | ||||||
Sweden | ||||||
Other foreign | ||||||
Total cash paid for income taxes, net of refunds | $ | $ | $ | |||
Exchange Tax Attributes | Pre-IPO M&A Tax Attributes | TRA Payment Tax Attributes | TRA Liabilities | |||||
Balance at December 31, 2023 | $ | $ | $ | $ | ||||
Exchange of LLC Common Units | ||||||||
Remeasurement – change in state rate | ( | ( | ( | ( | ||||
Remeasurement – foreign tax credits | ( | ( | ||||||
Interest expense | ||||||||
Payments | ( | ( | ( | ( | ||||
Balance at December 31, 2024 | $ | $ | $ | $ | ||||
Exchange of LLC Common Units | ||||||||
Interest expense | ||||||||
Payments | ( | ( | ( | ( | ||||
Balance at December 31, 2025 | $ | $ | $ | $ |
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Gain on interest rate cap | $( | $( | $( | |||
Gain on interest rate cap reclassified to earnings | ||||||
Foreign currency translation adjustments | ( | ( | ||||
Change in share of equity method investments’ other comprehensive income (loss) | ( | ( | ||||
Gain on Interest Rate Cap | Foreign Currency Translation Adjustments | Change in EMI Other Comprehensive Income (Loss)1 | Total | |||||
Balance at December 31, 2022 | $ | $ | $( | $ | ||||
Other comprehensive income (loss) before reclassifications | ( | |||||||
Amounts reclassified to earnings | ( | ( | ||||||
Other comprehensive income (loss) | $( | $ | $( | $( | ||||
Less: Non-controlling interests | ( | ( | ( | |||||
Balance at December 31, 2023 | $ | $ | $( | $ | ||||
Other comprehensive income (loss) before reclassifications | ( | |||||||
Amounts reclassified to earnings | ( | ( | ||||||
Other comprehensive income (loss) | $( | $( | $ | $( | ||||
Less: Non-controlling interests | ( | ( | ( | |||||
Balance at December 31, 2024 | $ | $( | $( | $( | ||||
Other comprehensive income before reclassifications | ||||||||
Amounts reclassified to earnings | ( | ( | ||||||
Other comprehensive income (loss) | $( | $ | $ | $ | ||||
Less: Non-controlling interests | ( | |||||||
Balance at December 31, 2025 | $ | $ | $ | $ |
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Net commissions and fees | $ | $ | $ | |||
Fiduciary investment income | ||||||
Total revenue | $ | $ | $ | |||
Compensation-related expense1 | ||||||
General and administrative expense2 | ||||||
Other segment items3 | ||||||
Depreciation and amortization | ||||||
Change in contingent consideration | ( | |||||
Interest income | ( | ( | ( | |||
Interest expense | ||||||
Income from equity method investments | ( | ( | ( | |||
Other non-operating loss (income) | ( | |||||
Income tax expense | ||||||
Net income | $ | $ | $ | |||
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
United States | $ | $ | $ | |||
Foreign | ||||||
Total revenue | $ | $ | $ | |||
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Cash paid for: | ||||||
Interest, net1 | $ | $ | $ | |||
Non-cash investing and financing activities: | ||||||
Non-controlling interest holders’ tax distributions declared but unpaid | $ | $ | $ | |||
Tax Receivable Agreement liabilities | ||||||
Dividend Equivalents and Declared Distributions liabilities | ||||||
Contingently returnable consideration | ||||||
Contingent consideration liabilities | ||||||
Year Ended December 31, | ||||||
2024 | 2023 | Total | ||||
Operations and technology optimization | $ | $ | $ | |||
Compensation and benefits | ||||||
Asset impairment and other termination costs | ||||||
Total | $ | $ | $ | |||
Operations and Technology Optimization | Compensation and Benefits | Asset Impairment and Other Termination Costs | Total | |||||
Balance at December 31, 2023 | $ | $ | $ | $ | ||||
Accrued costs | ||||||||
Payments | ( | ( | ( | |||||
Non-cash adjustments | ( | ( | ||||||
Balance at December 31, 2024 | $ | $ | $ | $ |
Exhibit Number | Description | ||
3.1 | |||
3.2 | |||
4.1 | |||
4.2 | |||
4.3 | |||
4.4 | |||
4.5 | |||
4.6 | |||
4.7 | |||
10.1 |
10.2 | |||
10.3 | + | ||
10.4 | + | ||
10.5 | |||
10.6 | + | ||
10.7 | + | ||
10.8 | + | ||
10.9 | + | ||
10.1 | + | ||
10.11 | + | ||
10.12 | + | ||
10.13 | + | ||
10.14 | + | ||
10.15 | + | ||
10.16 | |||
10.17 | |||
10.18 | |||
10.19 | + | ||
19.1 | |||
21.1 | |||
23.1 | |||
31.1 | |||
31.2 | |||
32.1 | * | ||
32.2 | * | ||
97.1 | |||
101.INS | Inline XBRL (Extensible Business Reporting Language) Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | ||
101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents | ||
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
Date February 12, 2026 | |||
Ryan Specialty Holding, Inc | |||
By: | /s/ Timothy W. Turner | ||
Timothy W. Turner, Chief Executive Officer | |||
Signature | Title | Date |
/s/ Patrick G. Ryan | Executive Chairman and Chairman of the Board of Director | February 12, 2026 |
Patrick G. Ryan | ||
/s/ Timothy W. Turner | Chief Executive Officer and Director (Principal Executive Officer) | February 12, 2026 |
Timothy W. Turner | ||
/s/ Janice M. Hamilton | Executive Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | February 12, 2026 |
Janice M. Hamilton | ||
/s/ Henry S. Bienen | Director | February 12, 2026 |
Henry S. Bienen | ||
/s/ David P. Bolger | Director | February 12, 2026 |
David P. Bolger | ||
/s/ Michael G Bungert | Director | February 12, 2026 |
Michael G. Bungert | ||
/s/ Michelle L. Collins | Director | February 12, 2026 |
Michelle L. Collins | ||
/s/ Francesca Cornelli | Director | February 12, 2026 |
Francesca Cornelli | ||
/s/ Nicholas D. Cortezi | Director | February 12, 2026 |
Nicholas D. Cortezi | ||
/s/ Anthony J. Kuczinski | Director | February 12, 2026 |
Anthony J. Kuczinski | ||
/s/ Michael D. O’Halleran | Director | February 12, 2026 |
Michael D. O’Halleran | ||
/s/ John W. Rogers, Jr | Director | February 12, 2026 |
John W. Rogers, Jr | ||
/s/ Patrick G. Ryan, Jr. | Director | February 12, 2026 |
Patrick G. Ryan, Jr. |